Bank of Nova Scotia
GH icon

Bank of Nova Scotia’s Guardant Health GH Stock Holding History

Bank of Nova Scotia’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-20,000
Closed -$2.5M – 1239
2021
Q3 		$2.5M Sell
20,000
-59,400
-75% -$7.06M ﹤0.01% 812
2021
Q2 		$9.86M Buy
+79,400
New +$10.7M 0.02% 445
2020
Q3 		– Sell
-73,598
Closed -$5.97M – 1029
2020
Q2 		$5.97M Buy
+73,598
New +$5.93M 0.02% 393

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bank of Nova Scotia's GH Position: Q4 2021 in Review

Bank of Nova Scotia sold out of Guardant Health (GH) in Q4 2021, closing a stake of 20,000 shares — an estimated $2.5M sold.

Bank of Nova Scotia first reported a position in GH in Q2 2020 and held it in 3 quarters. The position peaked at $9.86M in Q2 2021. 396 funds tracked by Wall St. Rank hold GH as of Q4 2021.

  • Bank of Nova Scotia reported no remaining Guardant Health position as of Q4 2021 after selling out during the quarter.
  • Bank of Nova Scotia sold 20,000 Guardant Health shares in Q4 2021, an estimated $2.5M.
  • Bank of Nova Scotia first reported a position in Guardant Health in Q2 2020 and held it in 3 quarters.
  • Bank of Nova Scotia's Guardant Health position peaked at $9.86M in Q2 2021.
  • 396 funds tracked by Wall St. Rank held Guardant Health as of Q4 2021.

Based on Bank of Nova Scotia's 13F filing for Q4 2021, filed 11 Feb 2022.